Form 4: Integra LifeSciences Executive Sells Shares

Eric Schwartz, EVP, Chief Legal Officer & Secretary of Integra LifeSciences, sold 4,070 shares of common stock on December 3, 2024.

Summary

• Eric Schwartz, an executive at Integra LifeSciences, sold 4,070 shares of the company's common stock on December 3, 2024.
• The sale was executed at a price of $24.595 per share.
• Following the transaction, Mr. Schwartz directly owns 59,511 shares of Integra LifeSciences common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, with no indication of positive or negative sentiment.

Industry Context

This is a routine disclosure of an insider transaction. Such filings are common and provide transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale by Eric Schwartz is similar to other executive stock sales, which are often part of personal financial planning or diversification strategies.
• The volume of shares sold is not unusual for an executive at this level.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's overall performance.

Key Dates

Keywords

Integra LifeSciences, IART, insider trading, stock sale, executive, Eric Schwartz, SEC Form 4